# QXO (QXO) — Investment Thesis

**Exchange:** NASDAQ  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-05-10  
**Tier:** Free primer (steps 1 & 3 of 19)  
**Sibling pages:** /stocks/QXO/financials · /stocks/QXO/memo

> This page shows the free thesis context (business model + recent catalysts).
> The full investment thesis (moat analysis, DCF, scenarios, risk register) is available
> via GET /api/v1/research/QXO/memo ($2.00, Bearer token).

## Recent Catalysts

# Step 15 — Scenario, Stress, and Base-Rate Analysis

## Key Findings

**Net Assessment: MIXED** — The scenario analysis reveals an asymmetric risk/reward profile: the bull case ($32-40/share) offers 28-60% upside while the bear case ($10-14) implies 44-60% downside. The base case ($18-22) is below the current price, meaning the market must assign >50% probability to the bull case to justify $25. Historical base rates for serial-acquirer roll-ups suggest a wide distribution of outcomes — the top decile (Jacobs' track record) dramatically outperforms, but the median roll-up destroys value through overpaying and integration failures. The Kahneman bias checklist reveals significant anchoring to Jacobs' historical returns and planning fallacy in the EBITDA doubling timeline.

---

## Narrative Analysis

### Scenario Construction

#### Bull Case (25% probability): $32-40/share

**Key assumptions:**
- EBITDA doubles to $2B+ by FY2029 (management target achieved)
- Organic revenue growth recovers to 4-5%/year
- Additional M&A at 8-10x EBITDA with 20-30% synergies
- Terminal EBITDA margin: 14-16% (BLDR-level)
- Market assigns 12-14x forward EBITDA
- Fully diluted shares: 1,100M (additional dilution from Series C + M&A)

**What must go right:**
1. Technology transformation creates measurable margin improvement by FY2027
2. Housing cycle normalizes (mortgage rates <6%, starts >1.5M)
3. HD/SRS does not initiate a price war in core roofing markets
4. At least 2-3 additional acquisitions at reasonable multiples ($2-5B each)
5. Jacobs remains active and healthy through the transformation

#### Base Case (45% probability): $18-22/share

**Key assumptions:**
- EBITDA reaches $1.5-1.8B by FY2029 (partial improvement, short of target)
- Organic revenue growth: 1-3%/year
- Limited additional M&A ($3-5B total over 4 years)
- Terminal EBITDA margin: 11-12.5%
- Market assigns 10-12x forward EBITDA
- Fully diluted shares: 1,050M

**What this looks like:**
- Jacobs achieves some operational improvements but falls short of the doubling target
- HD competition limits market share gains
- The stock trades sideways-to-down as the Jacobs premium gradually compresses toward operational reality

#### Bear Case (25% probability): $10-14/share

**Key assumptions:**
- EBITDA stays flat at $900M-1.1B (no meaningful margin expansion)
- Housing downturn: organic revenue declines 5-10%
- M&A pauses due to elevated multiples and/or liquidity constraints
- Terminal EBITDA margin: 9-10% (no improvement from current)
- Market assigns 8-10x forward EBITDA
- Preferred dividends and SBC consume $250-350M/year
- Fully diluted shares: 1,000M

**What triggers this:**
1. Recession — housing starts fall below 1.0M, commercial construction stalls
2. Integration failure — Beacon employees leave, customers switch, technology implementation stalls
3. Jacobs departure (health, dispute, distraction)
4. HD/SRS launches aggressive pricing campaign in QXO's top markets

#### Severe Downside (5% probability): $5-8/share

**Key assumptions:**
- Deep recession + integration failure
- Goodwill impairment ($2-3B write-down)
- Covenant violations requiring emergency capital raise at depressed prices
- Jacobs exits
- Market treats QXO as a leveraged cyclical at 5-7x EBITDA

### Probability-Weighted Expected Value

| Scenario | Probability | Per Share Value | Weighted Value |
|----------|------------|----------------|---------------|
| Bull | 25% | $36 (midpoint) | $9.00 |
| Base | 45% | $20 (midpoint) | $9.00 |
| Bear | 25% | $12 (midpoint) | $3.00 |
| Severe Downside | 5% | $6.50 | $0.33 |
| **Probability-Weighted Value** | **100%** | — | **$21.33** |

**The probability-weighted fair value of $21.33 is 15% below the current $25 price.**

### Historical Base Rates

#### Serial Acquirer Roll-Ups — What Does History Say?

| Outcome | Examples | Frequency | Key Success Factor |
|---------|---------|-----------|-------------------|
| **Top decile (10x+ returns)** | United Rentals, XPO, Danaher, TransDigm | ~10% | Operational playbook + capital discipline |
| **Good (3-10x returns)** | Waste Connections, Republic Services | ~15% | Steady compounding, no overpaying |
| **Average (1-3x returns)** | Most PE roll-ups | ~30% | Adequate execution, some overpaying |
| **Below average (0.5-1x)** | Numerous | ~25% | Overpaid for acquisitions, integration friction |
| **Failure (<0.5x)** | Valeant, Worldcom, Tyco | ~20% | Fraud, extreme leverage, financial engineering |

**QXO assessment:** Jacobs is in the top decile historically. But past performance does not guarantee future results (as QXO's own 10-K notes). The question is whether the building products distribution industry offers enough operational improvement opportunity at QXO's current scale to replicate top-decile returns.

#### EBITDA Doubling — Base Rate

How often do acquirers actually double the target's EBITDA?

| Company | Target EBITDA at Acquisition | Current/Final EBITDA | Outcome |
|---------|---------------------------|---------------------|---------|
| XPO (Jacobs, 2011-2019) | ~$50M (2011) | ~$1.6B (2019) | 32x — far exceeded doubling |
| United Rentals (Jacobs, 1997-2007) | ~$0 (startup) | ~$3B+ (2024) | N/A — built from scratch |
| HD + SRS (2024-present) | ~$1.1B (SRS 2023) | TBD | Too early |
| Lowe's + FBM (2025-present) | TBD | TBD | Too early |

Jacobs has done this before. But the starting point matters — doubling from $50M to $100M is very different from doubling from $900M to $1.8B. The law of large numbers makes each incremental dollar harder.

### Kahneman Bias Checklist

| Bias | Risk Level | Evidence |
|------|-----------|---------|
| **Anchoring** | HIGH | Anchoring to Jacobs' XPO/URI returns (50x, 200x). QXO starts at $18B market cap, not $150M. Expected returns must be far lower. |
| **Saliency** | HIGH | The Jacobs narrative dominates — one charismatic CEO makes the entire investment case memorable and emotionally compelling, potentially crowding out rigorous fundamental analysis. |
| **Planning Fallacy** | MEDIUM | "Double EBITDA in 5 years" implies ~15% CAGR — plausible but at the optimistic end. Timeline may stretch to 7-8 years. |
| **Groupthink** | MEDIUM | 13/13 analysts rate Buy or Strong Buy. Zero Sell ratings. Low short interest (0.81%). Consensus can be wrong. |
| **Competitor Neglect** | MEDIUM | HD's SRS entry is acknowledged but may be underweighted. HD has 20x QXO's resources. |
| **Sunk Cost / Halo Effect** | MEDIUM | Investors who bought at $9.14-12.30 have embedded gains that anchor their view. They may hold past fair value due to the "Jacobs halo." |

### Stress Test — Key Variables

| Variable | Base | Stressed | Impact on FY2028E EBITDA |
|----------|------|---------|-------------------------|
| Organic revenue growth | +3% | -5% (recession) | -$1.5B revenue → -$175M EBITDA |
| EBITDA margin | 11.5% | 9.0% (no improvement) | -$470M EBITDA |
| WACC | 9.5% | 11.5% (risk repricing) | -25% to equity value |
| Acquisition multiple | 10x | 14x (bidding war) | -30% ROIC on future deals |
| Share dilution | 1,050M | 1,200M (full Series C + more raises) | -$0.20/share EPS |

---

## Assumption Register Updates

| ID | Step | Assumption | Type | Value | Unit | Basis | Sensitivity | Source Tags |
|----|------|-----------|------|-------|------|-------|------------|-------------|
| A-50 | 15 | Probability-weighted fair value: $21.33/share | Estimate | 21.33 | $/share | Bull 25% / Base 45% / Bear 25% / Severe 5% | High | — |
| A-51 | 15 | Current price ($25) embeds >50% probability of bull case | Judgment | >50 | % | Reverse-implied from price vs scenarios | Medium | — |

---

## Source Index

| Source Tag | Document or URL | Section / Page | Date | Notes |
|------------|----------------|---------------|------|-------|
| All prior steps | — | — | — | Inputs from Steps 00-14 |

## Full Investment Thesis (Premium)

The full research tier adds these thesis-critical dimensions:

- Moat Analysis — durable competitive advantages, switching costs, network effects
- Investment Thesis — variant perception, what has to be true, why market may be wrong
- Bull / Base / Bear Scenarios — probability weights, catalysts, price targets
- Risk Register — macro, competitive, execution, regulatory risks with materiality ratings
- Management Quality — capital allocation track record, incentive alignment
- DCF Valuation — 10-year model with sensitivity matrix

**API endpoint:** GET /api/v1/research/QXO/memo

## Navigation

- Overview: /stocks/QXO
- Financials: /stocks/QXO/financials
- Thesis (this page): /stocks/QXO/thesis
- Investment Memo: /stocks/QXO/memo
- Coverage universe: /stocks